Clinical utility of CA-125 in the management of uterine carcinosarcoma

J Gynecol Oncol. 2018 Nov;29(6):e88. doi: 10.3802/jgo.2018.29.e88.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • CA-125 Antigen
  • Carcinosarcoma*
  • Female
  • Humans
  • United States
  • Uterine Neoplasms*

Substances

  • CA-125 Antigen